期刊文献+

多巴胺D_3受体选择性激动剂PD128907的合成 被引量:1

Synthesis of trans-racemic PD128907 as a dopamine D_3 receptor selective agonist
在线阅读 下载PDF
导出
摘要 目的合成多巴胺D3受体选择性激动剂PD128907。方法以对甲氧基苯酚为起始原料,经加成、酸解、环合、成肟、酯化、Neber重排、酰胺化、还原、环合、还原、烷基化以及脱甲基等12步反应制备了PD128907反式消旋体。结果以总收率4.75%合成了多巴胺D3受体选择性激动剂PD128907反式消旋体,结构经核磁氢谱(1H NMR)、质谱(MS)和红外光谱(IR)确证。结论对PD128907的合成进行了探讨,该法原料价廉易得,反应条件温和,收率较高。 AIM To synthesis trans-racemic PD128907 as a dobamine D3 receptor selective agonist. METHODS Starting from phydroxyanisole, trans-raeemic PD128907 was prepared by addition, hydrolysis, cyclization, oxSmation, estedfication, Neber arrangement, amidafion,reducfion,cyclizafion,reduction alkylation and demethylation reaction. RESULTS The total yield was 4.75%. The structure has been confirmed by ^1H NMR,MS and IR. CONCLUSIO The procedure has several advantages of cheap reagents,facile reaction conditions and high yield.
出处 《江苏药学与临床研究》 2006年第1期21-24,共4页 Jiangsu Pharmacertical and Clinical Research
基金 国家自然科学基金资助项目(项目批号:30472011)
关键词 多巴胺D3受体 帕金森综合症 PD128907 化学合成 Medicinal chemistry Chemical synthesis PD128907 Chemical synthesis
  • 相关文献

参考文献10

  • 1Alexander van Vliet, Nienke Rodenhuis, Durk Dijkstra, et al. Synthesis and plarmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR, 10bR )-( + )-trans-3, 4, 4a, 10b-tetrahydor-4- n-propyl-2H, 5H-[ 1 ] benzopyrano [ 4,3-b ]-1,4-oxazin-9-ol(PD 128907) [J]. J Meal Chem,2000,43:2871 - 2882.
  • 2朱爱芝.多巴胺D_3受体配体研究现状[J].国外医学(放射医学核医学分册),2002,26(2):53-57. 被引量:6
  • 3Ferraro TN, Golden GT, Berrettini WH, et al. Cocaine intake by rats correlates with cocaine-induced dopamine changes in the nucleus accumbens shell[J]. Pharmacol Biochem Behav ,2000,66:397 - 401.
  • 4顾莉洁,蔡进,李铭东,张姣月,吉民.多巴胺D_3受体配体的研究和应用[J].药学进展,2005,29(5):218-221. 被引量:8
  • 5Ji M, Chen JG, Ding K, et al. Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 ( D3 ) ligands [J].Bioorganic & Medicinal Chemistry Letters,2005,(15):1701-1705.
  • 6李铭东,严金秀,吉民.非典型抗精神病药物的研究进展[J].药学进展,2004,28(10):446-450. 被引量:20
  • 7Wiley PF. Amebicidal chromones[J]. J Am Chem Soc, 1951,73(9):4205 - 4209.
  • 8熊晓云,邹永,梅其炳,赵德化.6-甲氧基苯并二氢-γ-吡喃酮的合成工艺改进[J].中国医药工业杂志,2000,31(12):553-554. 被引量:8
  • 9Durk Dijkstra, Nienke Rodenhuis, Erik S vemeulen, et al. Further characterization of structural requirements for ligands at the dopamine D2 and D3 receptor:exploring the thiophene moiety[J]. J Med Chem,2002,45 : 3022 - 3031.
  • 10James H,Jones,Paul S, et al. Synthesis of 4-substituted 2H-naphth[ 1,2-b]-1,4-oxazines, a new class of dopamine agonists[J]. J Med Chem,1984,27:1607 - 1613.

二级参考文献58

  • 1陈俊杰 孙常晟 等.3-二烃氨基甲基-苯并氧六环-4-酶类衍生物的制备[J].化学学报,1956,22(6):455-455.
  • 2SmallJG CaseyD ArvanitisLA etal 赵靖平 朱荣华译.喹硫平-一种新的非典型抗精神病药[J].国外医学:精神病学分册,2000,27:36-39.
  • 3陈俊杰,化学学报,1956年,22卷,6期,455页
  • 4Shafer R A, Levant B. The D3 dopamine receptor in cellular and organismal function[J]. Psychopharmacology, 1998, 135:1-16.
  • 5Childress A R, O'Brien C P. Dopamine receptor partial agonists could address the duality of cocaine craving[J]. Trends Pharmacol Sci,2000,21:6-9.
  • 6Pilla M, Perachon S, Sautel F, et al. Selective inhibition of cocaine-seeking behavior by a partial dopamine D3 receptor agonist[J]. Nature,1999,400:371-375.
  • 7Foll B L, Schwartz J C, Sokoloff P. Dopamine D3 receptor agent as potential new medication for drug addiction[J]. Eur Psychiatry,2000,15:140-146.
  • 8Schwartz J C, Diaz J, Pilon C, et al. Possible implications of the dopamine D3 receptor in schizophrenia and in antipsy chotic drug actions[J]. Brain Res Brain Res Rev,2000,31:277-287.
  • 9Aston-Jones G, Druhan J. Breaking the chain of addiction[J]. Nature,1999, 400:317-319.
  • 10Hackling A, Ghosh R, Perachonet S, et al. N-(ω-(4-(2-Methoxyphenyl)piperazin-l-yl)alkyl)carboxamides as dopmine D2 and D3 receptor ligands[J]. J Med Chem,2003, 46:3883-3899.

共引文献34

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部